Literature DB >> 16553025

Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults.

Peter Gay1, Terri Weaver, Daniel Loube, Conrad Iber.   

Abstract

Positive airway pressure (PAP) is used to treat obstructive sleep apnea (OSA), central sleep apnea (CSA), and chronic hypoventilation. This document provides a systematic analysis and grading of peer-reviewed, published clinical studies pertaining to application of PAP treatment in adults. The paper is divided into 5 sections, each addressing a series of questions. The first section deals with whether efficacy and/or effectiveness have been demonstrated for continuous PAP (CPAP) treatment based on a variety of parameters and the level of OSA severity. Next, CPAP titration conducted with full, attended polysomnography in a sleep laboratory is compared with titration done under various other conditions. The third section investigates what can be expected regarding adherence and compliance with CPAP treatment as measured by subjective and objective methods and what factors may influence these parameters. Side effects and the influence of other specific factors on efficacy, effectiveness and safety of CPAP therapy are evaluated in the fourth section. Finally, the use of bilevel PAP therapy is reviewed for both patients with OSA and those with other selected nocturnal breathing disorders. Each section also contains a brief summary and suggestions for future research.

Entities:  

Mesh:

Year:  2006        PMID: 16553025     DOI: 10.1093/sleep/29.3.381

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  171 in total

1.  Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis.

Authors:  Yongzhong Guo; Lei Pan; Dunqiang Ren; Xiaomei Xie
Journal:  Sleep Breath       Date:  2012-06-05       Impact factor: 2.816

2.  Sleep apnea in fragile X premutation carriers with and without FXTAS.

Authors:  Alyssa Hamlin; Ying Liu; Danh V Nguyen; Flora Tassone; Lin Zhang; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-09-19       Impact factor: 3.568

3.  The lesser of two evils.

Authors:  Barbara Riegel; Amy M Sawyer; Joseph Libonati
Journal:  Sleep       Date:  2011-12-01       Impact factor: 5.849

Review 4.  Factors that influence CPAP adherence: an overview.

Authors:  Gilla K Shapiro; Colin M Shapiro
Journal:  Sleep Breath       Date:  2010-07-27       Impact factor: 2.816

5.  Predictive equations for CPAP titration in OSAS patients.

Authors:  Donato Lacedonia; Roberto Sabato; Giovanna E Carpagnano; Pierluigi Carratù; Antonio Falcone; Felice Gadaleta; Onofrio Resta; Maria P Foschino Barbaro
Journal:  Sleep Breath       Date:  2011-01-06       Impact factor: 2.816

6.  Do cognitive perceptions influence CPAP use?

Authors:  Amy M Sawyer; Anne Canamucio; Helene Moriarty; Terri E Weaver; Kathy C Richards; Samuel T Kuna
Journal:  Patient Educ Couns       Date:  2010-11-10

7.  A Young Man Running Out of Treatment Options.

Authors:  Ankur Girdhar; Richard B Berry; Scott Ryals; Emily Beck; Mary Wagner
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

8.  Success in blinding to group assignment with sham-CPAP.

Authors:  Eileen R Chasens; Oliver J Drumheller; Patrick J Strollo
Journal:  Biol Res Nurs       Date:  2012-10-02       Impact factor: 2.522

9.  A new characterization of adherence patterns to auto-adjusting positive airway pressure in severe obstructive sleep apnea syndrome: clinical and psychological determinants.

Authors:  Rute Sampaio; M Graça Pereira; João C Winck
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

10.  Childhood adversity and sleep are associated with symptom severity in perinatal women presenting for psychiatric care.

Authors:  Rena A Menke; Leslie Swanson; Nora L Erickson; Greta Reglan; Stephanie Thompson; Katherine Harris Bullard; Katherine Rosenblum; Juan P Lopez; Maria Muzik
Journal:  Arch Womens Ment Health       Date:  2018-10-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.